发明名称 Approach for synthesis of catechins
摘要 A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+ and/or −) epicatechin and its intermediates, comprising the steps of: (i) obtaining penta-protected quercetin; (ii) reducing the penta-protected quercetin obtained from step (i); (iii) optionally deprotecting the compound of step (ii); (iv) reducing the compound obtained from step (ii) or step (iii) in the presence of a chiral/achiral reducing agent to obtain a chiral intermediate; (v) deprotecting and/or hydrogenation of the chiral intermediate obtained from step (iv) to obtain (−)-epicatechin; (vi) optionally simultaneously deprotecting and by drogenation of the compound obtained from step (ii) to obtain racemic epicatechin.
申请公布号 US9556140(B2) 申请公布日期 2017.01.31
申请号 US201414763018 申请日期 2014.01.27
申请人 Sphaera Pharma Pvt. Ltd. 发明人 Dugar Sundeep;Mahajan Dinesh;Rai Kumar Santosh;Tripathi Vinayak;Patil Ishwar Rakesh
分类号 C07D311/62;A61K31/353;C07D311/30;C07D311/32;C07F7/18 主分类号 C07D311/62
代理机构 Foley Hoag LLP 代理人 Foley Hoag LLP
主权项 1. A process for synthesis of enatiomerically pure epicatechin, or enatiomerically enriched epicatechin, or a racemic mixture of (+) and (−) epicatechin, or its intermediates, comprising: I. obtaining penta-protected quercetin in one or more than one selective protection steps; II. reducing the penta-protected quercetin obtained from step I; III. optionally deprotecting the compound of step II; IV. reducing the compound obtained from step II or step III in the presence of a chiral/achiral reducing agent to obtain a chiral intermediate; and V. deprotecting and/or hydrogenating the chiral intermediate obtained from step IV to obtain (−)-epicatechin; or VI. optionally simultaneously deprotecting and hydrogenating the compound obtained from step II to obtain racemic epicatechin.
地址 Haryana IN